Analysing tumour DNA in addition to biopsies could give clinicians a more nuanced view of a patient’s disease progression and could potentially impact treatment direction, an expert has told HAA delegates. Speaking at the HAA 2017 scientific meeting in Sydney this week Dr. Piers Blombery, medical lead at the molecular haematology laboratory at the Peter MacCallum ...
Tumour DNA provides clearer genetic profiles of lymphoid malignancy
By Ivy Shih
31 Oct 2017